| Diabetic kidney disease MC Thomas, M Brownlee, K Susztak, K Sharma, KAM Jandeleit-Dahm, ... Nature reviews Disease primers 1 (1), 1-20, 2015 | 978 | 2015 |
| Angiotensin‐converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease C Tikellis, MC Thomas International journal of peptides 2012 (1), 256294, 2012 | 775 | 2012 |
| The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes PH Groop, MC Thomas, JL Moran, J Waden, LM Thorn, VP Mäkinen, ... Diabetes 58 (7), 1651-1658, 2009 | 743 | 2009 |
| Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease MC Thomas, ME Cooper, P Zimmet Nature Reviews Nephrology 12 (2), 73-81, 2016 | 687 | 2016 |
| A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes R Candido, JM Forbes, MC Thomas, V Thallas, RG Dean, WC Burns, ... Circulation research 92 (7), 785-792, 2003 | 653 | 2003 |
| Suppression of microRNA-29 expression by TGF-β1 promotes collagen expression and renal fibrosis B Wang, R Komers, R Carew, CE Winbanks, B Xu, M Herman-Edelstein, ... Journal of the American Society of Nephrology 23 (2), 252-265, 2012 | 600 | 2012 |
| Low testosterone levels are common and associated with insulin resistance in men with diabetes M Grossmann, MC Thomas, S Panagiotopoulos, K Sharpe, RJ MacIsaac, ... The journal of clinical endocrinology & metabolism 93 (5), 1834-1840, 2008 | 552 | 2008 |
| Unrecognized anemia in patients with diabetes: a cross-sectional survey MC Thomas, RJ MacIsaac, C Tsalamandris, D Power, G Jerums Diabetes care 26 (4), 1164-1169, 2003 | 544 | 2003 |
| Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study) LM Thorn, C Forsblom, J Fagerudd, MC Thomas, K Pettersson-Fernholm, ... Diabetes care 28 (8), 2019-2024, 2005 | 527 | 2005 |
| Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes A Soro-Paavonen, AMD Watson, J Li, K Paavonen, A Koitka, AC Calkin, ... Diabetes 57 (9), 2461-2469, 2008 | 499 | 2008 |
| Role of advanced glycation end products in diabetic nephropathy JM Forbes, ME Cooper, MD Oldfield, MC Thomas Journal of the American Society of Nephrology 14 (suppl_3), S254-S258, 2003 | 453 | 2003 |
| Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis JM Forbes, LTL Yee, V Thallas, M Lassila, R Candido, ... Diabetes 53 (7), 1813-1823, 2004 | 425 | 2004 |
| The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes MC Thomas, J Moran, C Forsblom, V Harjutsalo, L Thorn, A Ahola, ... Diabetes care 34 (4), 861-866, 2011 | 417 | 2011 |
| miR-200a prevents renal fibrogenesis through repression of TGF-β2 expression B Wang, P Koh, C Winbanks, MT Coughlan, A McClelland, A Watson, ... diabetes 60 (1), 280-287, 2011 | 412 | 2011 |
| Improved islet morphology after blockade of the renin-angiotensin system in the ZDF rat C Tikellis, PJ Wookey, R Candido, S Andrikopoulos, MC Thomas, ... Diabetes 53 (4), 989-997, 2004 | 409 | 2004 |
| Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy JM Forbes, ME Cooper, V Thallas, WC Burns, MC Thomas, GC Brammar, ... Diabetes 51 (11), 3274-3282, 2002 | 403 | 2002 |
| Dietary salt intake and mortality in patients with type 2 diabetes EI Ekinci, S Clarke, MC Thomas, JL Moran, K Cheong, RJ MacIsaac, ... Diabetes care 34 (3), 703-709, 2011 | 400 | 2011 |
| An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function FA Holtkamp, D De Zeeuw, MC Thomas, ME Cooper, PA De Graeff, ... Kidney international 80 (3), 282-287, 2011 | 369 | 2011 |
| The breakdown of pre‐existing advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes JM Forbes, V Thallas, MC Thomas, HW Founds, WC Burns, G Jerums, ... The FASEB Journal 17 (12), 1762-1764, 2003 | 354 | 2003 |
| The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure MC Thomas, DZI Cherney Diabetologia 61, 2098-2107, 2018 | 351 | 2018 |
